Abm Shakil Gani, Abdullah Al Mahmood, Afm Shafiqul Alam, Mizanur Rahman, Raqibul Alam, Tasnim Mahmud
{"title":"孟加拉国无症状健康脂肪肝患者的糖尿病发病率较高:及时干预可避免并发症。","authors":"Abm Shakil Gani, Abdullah Al Mahmood, Afm Shafiqul Alam, Mizanur Rahman, Raqibul Alam, Tasnim Mahmud","doi":"10.5005/jp-journals-10018-1444","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The strong association between type 2 diabetes mellitus (T2DM) and fatty liver is well known, and its nomenclature has even recently changed to metabolic dysfunction-associated steatotic liver disease (MASLD). Healthy MASLD patients are frequently overlooked and maltreated, especially in Bangladesh. In this present study, we tried to correlate T2DM burden in apparently healthy, incidentally diagnosed fatty liver patients on ultrasound.</p><p><strong>Materials and methods: </strong>This cross-sectional study was done in Sheikh Hasina Medical College Hospital, Tangail, Bangladesh, from August 2022 to February 2023. A total of 92 patients with ultrasonological evidence of grade II fatty change in the liver were included and evaluated. Known T2DM, hypothyroidism, consumption of alcohol, HBV or HCV infection, Wilson's disease, autoimmune liver disease, hemochromatosis, and any other chronic liver or kidney disease patients were excluded. The patients were then assessed for the presence and absence of T2DM using OGTT (2 hours 75 gm glucose ≥ 11.1 mmol/L) and/or HbA1c (≥6.5%) as diagnostic criteria. Data was analyzed by SPSS, version 23.</p><p><strong>Results: </strong>Out of 92 patients, 48 were male and 44 were female. A total of 50 patients (54.3%) were newly diagnosed with T2DM. Statistically significant differences were seen in the T2DM group and non-DM group for AST (50.33 IU vs 36.53 IU) and TG (270 mg/dL vs 189 mg/dL). Although no noteworthy differences were evident in mean age (41 years vs 38 years), ALT (58.9 IU vs 60.23 IU), and BMI (28.85 vs 29.29).</p><p><strong>Conclusions: </strong>In the present study, more than 54% of patients with grade II fatty liver were newly diagnosed with T2DM. They would later present with more advanced T2DM and related complications. Although a larger study is needed, physicians and healthcare workers in Bangladesh should be more concerned about treating MASLD patients with early diagnosis of T2DM, recommending prompt lifestyle interventions, and prescribing drugs if necessary.</p><p><strong>How to cite this article: </strong>Gani ABMS, Mahmood AA, Alam AFMS, <i>et al.</i> Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications. Euroasian J Hepato-Gastroenterol 2024;14(2):172-175.</p>","PeriodicalId":516317,"journal":{"name":"Euroasian journal of hepato-gastroenterology","volume":"14 2","pages":"172-175"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714108/pdf/","citationCount":"0","resultStr":"{\"title\":\"Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications.\",\"authors\":\"Abm Shakil Gani, Abdullah Al Mahmood, Afm Shafiqul Alam, Mizanur Rahman, Raqibul Alam, Tasnim Mahmud\",\"doi\":\"10.5005/jp-journals-10018-1444\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The strong association between type 2 diabetes mellitus (T2DM) and fatty liver is well known, and its nomenclature has even recently changed to metabolic dysfunction-associated steatotic liver disease (MASLD). Healthy MASLD patients are frequently overlooked and maltreated, especially in Bangladesh. In this present study, we tried to correlate T2DM burden in apparently healthy, incidentally diagnosed fatty liver patients on ultrasound.</p><p><strong>Materials and methods: </strong>This cross-sectional study was done in Sheikh Hasina Medical College Hospital, Tangail, Bangladesh, from August 2022 to February 2023. A total of 92 patients with ultrasonological evidence of grade II fatty change in the liver were included and evaluated. Known T2DM, hypothyroidism, consumption of alcohol, HBV or HCV infection, Wilson's disease, autoimmune liver disease, hemochromatosis, and any other chronic liver or kidney disease patients were excluded. The patients were then assessed for the presence and absence of T2DM using OGTT (2 hours 75 gm glucose ≥ 11.1 mmol/L) and/or HbA1c (≥6.5%) as diagnostic criteria. Data was analyzed by SPSS, version 23.</p><p><strong>Results: </strong>Out of 92 patients, 48 were male and 44 were female. A total of 50 patients (54.3%) were newly diagnosed with T2DM. Statistically significant differences were seen in the T2DM group and non-DM group for AST (50.33 IU vs 36.53 IU) and TG (270 mg/dL vs 189 mg/dL). Although no noteworthy differences were evident in mean age (41 years vs 38 years), ALT (58.9 IU vs 60.23 IU), and BMI (28.85 vs 29.29).</p><p><strong>Conclusions: </strong>In the present study, more than 54% of patients with grade II fatty liver were newly diagnosed with T2DM. They would later present with more advanced T2DM and related complications. Although a larger study is needed, physicians and healthcare workers in Bangladesh should be more concerned about treating MASLD patients with early diagnosis of T2DM, recommending prompt lifestyle interventions, and prescribing drugs if necessary.</p><p><strong>How to cite this article: </strong>Gani ABMS, Mahmood AA, Alam AFMS, <i>et al.</i> Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications. Euroasian J Hepato-Gastroenterol 2024;14(2):172-175.</p>\",\"PeriodicalId\":516317,\"journal\":{\"name\":\"Euroasian journal of hepato-gastroenterology\",\"volume\":\"14 2\",\"pages\":\"172-175\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714108/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Euroasian journal of hepato-gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/jp-journals-10018-1444\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Euroasian journal of hepato-gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10018-1444","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:2型糖尿病(T2DM)与脂肪肝之间的密切联系是众所周知的,其命名最近甚至已改为代谢功能障碍相关脂肪变性肝病(MASLD)。健康的MASLD患者经常被忽视和虐待,特别是在孟加拉国。在本研究中,我们试图通过超声检查将表面健康的偶然诊断为脂肪肝的患者的T2DM负担联系起来。材料和方法:本横断面研究于2022年8月至2023年2月在孟加拉国坦盖尔的谢赫哈西娜医学院医院完成。共纳入92例有肝脏II级脂肪改变超声证据的患者并进行评估。排除已知的T2DM、甲状腺功能减退、饮酒、HBV或HCV感染、Wilson病、自身免疫性肝病、血色素沉着症和任何其他慢性肝脏或肾脏疾病患者。然后以OGTT(2小时75克葡萄糖≥11.1 mmol/L)和/或HbA1c(≥6.5%)作为诊断标准评估患者是否存在T2DM。数据分析采用SPSS,版本23。结果:92例患者中,男性48例,女性44例。共有50例(54.3%)新诊断为T2DM。T2DM组和非dm组AST (50.33 IU vs 36.53 IU)和TG (270 mg/dL vs 189 mg/dL)差异有统计学意义。虽然在平均年龄(41岁vs 38岁)、ALT (58.9 IU vs 60.23 IU)和BMI (28.85 vs 29.29)方面没有明显的差异。结论:在本研究中,超过54%的II级脂肪肝患者新诊断为T2DM。他们后来会出现更严重的2型糖尿病和相关并发症。尽管需要进行更大规模的研究,但孟加拉国的医生和卫生保健工作者应该更加关注对早期诊断为2型糖尿病的MASLD患者的治疗,建议及时干预生活方式,并在必要时开药。如何引用本文:Gani ABMS, Mahmood AA, Alam AFMS等。孟加拉国无症状健康脂肪肝患者糖尿病发病率较高:及时干预可避免并发症中华肝病与胃肠病杂志;2009;14(2):172-175。
Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications.
Background: The strong association between type 2 diabetes mellitus (T2DM) and fatty liver is well known, and its nomenclature has even recently changed to metabolic dysfunction-associated steatotic liver disease (MASLD). Healthy MASLD patients are frequently overlooked and maltreated, especially in Bangladesh. In this present study, we tried to correlate T2DM burden in apparently healthy, incidentally diagnosed fatty liver patients on ultrasound.
Materials and methods: This cross-sectional study was done in Sheikh Hasina Medical College Hospital, Tangail, Bangladesh, from August 2022 to February 2023. A total of 92 patients with ultrasonological evidence of grade II fatty change in the liver were included and evaluated. Known T2DM, hypothyroidism, consumption of alcohol, HBV or HCV infection, Wilson's disease, autoimmune liver disease, hemochromatosis, and any other chronic liver or kidney disease patients were excluded. The patients were then assessed for the presence and absence of T2DM using OGTT (2 hours 75 gm glucose ≥ 11.1 mmol/L) and/or HbA1c (≥6.5%) as diagnostic criteria. Data was analyzed by SPSS, version 23.
Results: Out of 92 patients, 48 were male and 44 were female. A total of 50 patients (54.3%) were newly diagnosed with T2DM. Statistically significant differences were seen in the T2DM group and non-DM group for AST (50.33 IU vs 36.53 IU) and TG (270 mg/dL vs 189 mg/dL). Although no noteworthy differences were evident in mean age (41 years vs 38 years), ALT (58.9 IU vs 60.23 IU), and BMI (28.85 vs 29.29).
Conclusions: In the present study, more than 54% of patients with grade II fatty liver were newly diagnosed with T2DM. They would later present with more advanced T2DM and related complications. Although a larger study is needed, physicians and healthcare workers in Bangladesh should be more concerned about treating MASLD patients with early diagnosis of T2DM, recommending prompt lifestyle interventions, and prescribing drugs if necessary.
How to cite this article: Gani ABMS, Mahmood AA, Alam AFMS, et al. Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications. Euroasian J Hepato-Gastroenterol 2024;14(2):172-175.